Xiao‐Song Wang

EnSEMBLE reduces redundant gene sets to enhancer-corroborated pathways by integrating enhancer RNA data with pathway enrichment analysis, improving biological relevance and reducing false positives.

This study shows ER fusion proteins in breast cancer cell lines drive ligand-independent pro-oncogenic pathways, with subtype- and fusion-specific effects.

IndepthPathway improves pathway enrichment analysis for single-cell and bulk RNA-seq by addressing noise and low coverage issues through the WCSEA algorithm.

This paper introduces iGenSig, a genomic signature method for predicting cancer therapy responses using genome-wide sequencing data, showing strong cross-dataset performance and resilience to sequencing errors.